Lexicon Pharmaceuticals, Inc. (LXRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 1.6500 |
| Open | 1.7500 |
| Bid | 1.6900 x 1400 |
| Ask | 1.7200 x 1800 |
| Day's range | 1.6500 - 1.7500 |
| 52-week range | 0.9200 - 3.7900 |
| Volume | |
| Avg. volume | 4,572,564 |
| Market cap | 418.603M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.8000 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 5.25 |
- Thomson Reuters StreetEvents
Q1 2024 Lexicon Pharmaceuticals Inc Earnings Call
Q1 2024 Lexicon Pharmaceuticals Inc Earnings Call
- GuruFocus.com
Lexicon Pharmaceuticals Inc (LXRX) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
Despite a net loss, Lexicon Pharmaceuticals Inc (LXRX) shows promising advancements in drug development and strategic financial maneuvers.
ZacksLexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Misses Revenue Estimates
Lexicon (LXRX) delivered earnings and revenue surprises of -11.11% and 3.09%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.